[Fatty liver. Not only ultrasound to be relied on!].
Füessl
H S
HS
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control; D005234:Fatty Liver / Q000150:complications / Q000000981:diagnostic imaging*; D005260:Female; D006505:Hepatitis / Q000188:drug therapy / Q000209:etiology; D006526:Hepatitis C / Q000635:transmission; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control; D008297:Male; D010865:Pilot Projects; D000077205:Pioglitazone; D011247:Pregnancy; D011446:Prospective Studies; D012307:Risk Factors; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014463:Ultrasonography
D000998:Antiviral Agents; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D007372:Interferons; D000077205:Pioglitazone